MDCO: Medicines Company Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MDCO: Medicines Company

MDCO 84.90

0.0%

Jan 6 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Rich1 who wrote (42)	2/13/2003 7:32:01 AM
From: Mike	Read Replies (1) of 125

MDCO is currently under accumulation. On the days that we have up days volume is over 1M. On the down days we have only average daily volume of 450K. I am not good at technical analysis but this is a good sign. The Replace II results should be published in JAMA next week. For the ones that are new to MDCO Replace II was the trial that looked at the Angiomax. This was a huge trial. Below is some info on that trial. The Medicines Company's REPLACE-2 Clinical Trial Meets Primary and Secondary Endpoints for Angiomax -bivalirudin biz.yahoo.com Remember too that they announced earnings recently. They confirmed guidance for next year. That guidance is for sales in the $70M-$90M range and loss of approx $20M. I think this loss is based on sales of $70M and they will breakeven on sales of $90M. The Medicines Company Reports Fourth Quarter and Full Year 2002 Financial Results Tuesday February 11, 4:27 pm ET -- 2002 revenues up 169% compared to 2001 biz.yahoo.com Good investing all, Mike

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next